A brighter future for patientswithamyotrophic lateral sclerosis through imaging?

JAMA Neurology

Volumn 71, Issue 5, 2014, Pages 539-540

  Foerster, Bradley R ^a,b   Feldman, Eva L ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; C9ORF72 PROTEIN, HUMAN; DIAGNOSTIC AGENT; PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN METABOLISM; BRAIN REGION; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; EDITORIAL; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREMOTOR CORTEX; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; FEMALE; GENETICS; MALE; NOTE; SCINTISCANNING; STANDARD;

AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROTEINS;

EID: 84900494282     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.66     Document Type: Editorial

References (10)

1. Van Laere K, Vanhee A, Verschueren J, et al. Value of 18fluorodeoxyglucosepositron-emission tomography in amyotrophic lateral sclerosis: a prospective study [published online March 10, 2014]. JAMA Neurol. doi:10.1001/ jamaneurol.2014.62.
2. van der Graaff MM, Lavini C, Akkerman EM, et al. MR spectroscopy findings in early stages of motor neuron disease. AJNR Am J Neuroradiol. 2010;31(10):1799-1806.
3. van der Graaff MM, Sage CA, CaanMW, et al. Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study. Brain. 2011;134(pt 4):1211-1228.
4. Turner MR, Agosta F, Bede P, Govind V, Lulé D, Verstraete E. Neuroimaging in amyotrophic lateral sclerosis. Biomark Med. 2012;6(3):319-337.
5. Cistaro A, Valentini MC, Chì A, et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging. 2012;39(2):251-259.
6. Borghammer P, Cumming P, Aanerud J, F̈rster S, Gjedde A. Subcortical elevation ofmetabolism in Parkinsons diseasea critical reappraisal in the context of global mean normalization. Neuroimage. 2009;47(4):1514-1521.
7. Ludolph AC, Langen KJ, RegardM, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand. 1992;85(2):81-89.
8. Abrahams S, Leigh PN, Kew JJ, Goldstein LH, Lloyd CM, Brooks DJ. A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. J Neurol Sci. 1995;129(suppl):44-46.
9. Sackett DL, Haynes RB. The architecture of diagnostic research. BMJ. 2002;324(7336): 539-541.
10. Bos suyt PM, Reitsma JB, Bruns DE, et al; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Ann Intern Med. 2003;138(1):40-44.